The Procter & Gamble Company (NYSE:PG) Shares Purchased by Adero Partners LLC

Adero Partners LLC increased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 5.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,033 shares of the company’s stock after purchasing an additional 273 shares during the quarter. Adero Partners LLC’s holdings in Procter & Gamble were worth $830,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of PG. Advantage Trust Co purchased a new position in Procter & Gamble during the fourth quarter valued at approximately $28,000. Transcendent Capital Group LLC purchased a new position in Procter & Gamble during the fourth quarter valued at approximately $31,000. Ruedi Wealth Management Inc. raised its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. MeadowBrook Investment Advisors LLC purchased a new position in Procter & Gamble during the fourth quarter valued at approximately $33,000. Finally, POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $34,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

NYSE PG opened at $171.53 on Friday. The stock’s fifty day moving average is $167.42 and its two-hundred day moving average is $163.93. The firm has a market capitalization of $404.83 billion, a P/E ratio of 28.03, a price-to-earnings-growth ratio of 3.64 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $171.89.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the previous year, the company posted $1.37 earnings per share. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. On average, research analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Barclays cut their price objective on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a research report on Wednesday, July 31st. Citigroup boosted their price objective on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and cut their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $175.79.

Check Out Our Latest Report on Procter & Gamble

Insider Activity

In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. The disclosure for this sale can be found here. Insiders have sold a total of 375,553 shares of company stock valued at $63,829,141 in the last quarter. Insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.